Latest Research Demonstrates Promising Improved Glucose Homeostasis by Reprogramming Alpha Cells
AUSTIN, Texas, June 24, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...
- Enables streamlined stability testing and release of higher quality AAV-based gene therapy products.
- Provides much needed European capacity for AAV characterization and release.
ROCKVILLE,...